Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Tilray Brands, Inc. TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The... see more

NDAQ:TLRY - Post Discussion

Tilray Brands, Inc. > Germany Legalization
View:
Post by CaneIsAbel on Feb 08, 2024 9:03am

Germany Legalization

Will have the biggest impact for Tilray Brands of all companies that engage in cannabis sales. Tilray Pharma commands over 20 percent medical market share in the country with a DOMESTIC production GMP certified facility within the country. Some of the biggest MSO advocates admit this to be fact the dales report. Stands a reason Hudson Bay capital increased its postion to 38 million value more then all institutional investment in every MSO combined. Just about anyway
Comment by Oldweed on Feb 08, 2024 9:16am
Medical cannabis in Europe is definately a great opportunity, but there are other factors that need to be considered alongside. First, medical sales represent 20% of the market, the other 80% is retail. So even if it were true that Tilray has 20% of the 20% of the total MJ market in Germany I have to question how many years will it take to get to the scale required for profitability? Tilray has ...more  
Comment by CaneIsAbel on Feb 08, 2024 9:23am
You understand I've determined most of these short distort TLRY accounts are Matt lamers?  So we've there plans for private groupings that can shutter the noise you all bring and distortions. Tilray Brands, like Curaleaf and MSO's have  been highly taxed and regulations have made profitability hard to attain. Canada also has changing regulations on the docket regarding Tax ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities